<p>(A) Growth inhibition curve of Kae on BHK21 cells for 72 h. CC<sub>50</sub> was 230 µM. (B) Growth inhibition curve of Dai on BHK21 cells for 72 h. CC<sub>50</sub> was 270 µM. (C) Anti-JEV effects of Kae and Dai when cells were pretreated for 2 h before infection with 0.1 MOI JEV for 72 h. EC<sub>50</sub> for Kae and Dai at 72 h were 12.6 and 25.9 µM, respectively. (D) Comparison of anti-JEV effects of combination treatment with Kae and Dai when cells received combined pretreatment for 2 h, and were then infected with 0.1 MOI JEV for 72 h. (E) Anti-JEV effects of Kae and Dai when cells were infected with 0.1 MOI JEV for 2 h and then treated with Kae or Dai for 72 h. EC<sub>50</sub> was 21.5 µM for Kae and 40.4 µM for Dai. (F) Comparison ...
<p>A). IHC infectivity assay showing cells 48 hours post infection stained for NS5A expression. Indi...
<p>(A) Concentration-response relationship of Yan 7874. (B) The impact of the inhibition of caspases...
<p>(A-B) Inhibitory effects of amantadine hydrochloride, oseltamivir phosphate and ribavirin. A549-5...
<p>(A) Histogram of JEV E, NS1 and NS1' protein expression levels in cells infected and then treated...
<p>(A) mRNA expression level of JEV-infected cells (mock infection) was defined as 100%. The amount ...
<p>Effects of genipin on KSHV infection to iSLK-puro cells were determined by KSHV infection assay. ...
<p>ARPE19 cells were treated with 6-15 µM 7KCh for 24 hr and the cell viability was measured by dete...
A. 48 hours after infection with KSHV, ECFCLY (squares), ECFCBL (circles), K-ECFCLY (upside down tri...
<p>(A) The DPPH radical scavenging assay. (B) The ABTS radical scavenging assay. (C) IC<sub>50</sub>...
<p>A) Effects of test compounds at different concentrations on HeLa cells following treatment for 24...
<p>(a). MV-4-11 cells were plated in 96-well clear bottom plates and treated with DRE at indicated t...
<p>A) U87MGs were untreated, DMSO treated or pretreated with IKK inhibitors (1 µM) for 2 hours and 2...
<p>(<b>A</b>) K22 structure. (<b>B</b>) Anti-HCoV-229E activity of K22 in MRC-5 cells. K22 and HCoV-...
The iSLK.219 cells were treated by indicated concentrations of compounds with the addition of Dox (0...
(A) Susceptibility of human cell lines to JEV. Human cell lines were infected with JEV (MOI = 5) and...
<p>A). IHC infectivity assay showing cells 48 hours post infection stained for NS5A expression. Indi...
<p>(A) Concentration-response relationship of Yan 7874. (B) The impact of the inhibition of caspases...
<p>(A-B) Inhibitory effects of amantadine hydrochloride, oseltamivir phosphate and ribavirin. A549-5...
<p>(A) Histogram of JEV E, NS1 and NS1' protein expression levels in cells infected and then treated...
<p>(A) mRNA expression level of JEV-infected cells (mock infection) was defined as 100%. The amount ...
<p>Effects of genipin on KSHV infection to iSLK-puro cells were determined by KSHV infection assay. ...
<p>ARPE19 cells were treated with 6-15 µM 7KCh for 24 hr and the cell viability was measured by dete...
A. 48 hours after infection with KSHV, ECFCLY (squares), ECFCBL (circles), K-ECFCLY (upside down tri...
<p>(A) The DPPH radical scavenging assay. (B) The ABTS radical scavenging assay. (C) IC<sub>50</sub>...
<p>A) Effects of test compounds at different concentrations on HeLa cells following treatment for 24...
<p>(a). MV-4-11 cells were plated in 96-well clear bottom plates and treated with DRE at indicated t...
<p>A) U87MGs were untreated, DMSO treated or pretreated with IKK inhibitors (1 µM) for 2 hours and 2...
<p>(<b>A</b>) K22 structure. (<b>B</b>) Anti-HCoV-229E activity of K22 in MRC-5 cells. K22 and HCoV-...
The iSLK.219 cells were treated by indicated concentrations of compounds with the addition of Dox (0...
(A) Susceptibility of human cell lines to JEV. Human cell lines were infected with JEV (MOI = 5) and...
<p>A). IHC infectivity assay showing cells 48 hours post infection stained for NS5A expression. Indi...
<p>(A) Concentration-response relationship of Yan 7874. (B) The impact of the inhibition of caspases...
<p>(A-B) Inhibitory effects of amantadine hydrochloride, oseltamivir phosphate and ribavirin. A549-5...